Equazen ® Reaffirms Its Commitment to Uncompromising Quality and Sustainability in Omegas Supplements
LUGANO, Switzerland--(BUSINESS WIRE)--SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, highlights today its ongoing commitment to delivering the highest standard of quality for Equazen ®, the company's global science-based food supplement brand designed to nourish, enhance and support the brain's potential.
'Our mission with Equazen® is to provide natural supplements that parents and caregivers can trust to support cognitive needs. This is made possible only through ethical sourcing, advanced manufacturing, and robust scientific validation." Matthew Brabazon
Share
At SFI Health™, quality is more than a requirement—it is a mission. The company is committed to enhancing people's well-being by developing natural supplements that combine passion for nature-based healthcare, science, state-of-the-art production standards and sustainability, from ingredient sourcing to the final product reaching the patient.
In particular, with over 25 years of trust built across multiple markets, Equazen ® 's excellence is built on five core pillars:
Ingredients Sourcing: Equazen ® 's story begins in the sea, with responsibly sourced fish oil rich in essential Omega-3 fatty acids EPA and DHA, paired with cold-pressed evening primrose and borage seeds oils for Omega-6 (GLA). Every ingredient is carefully selected from certified suppliers, processed using validated methods ensuring purity and safety as well as full traceability in compliance with European Pharmacopoeia regulations. Besides, Equazen ® suppliers are part of the IFFO, the international marine ingredients organization, promoting responsible sourcing and high-quality manufacturing in the industry of fish oil.
Manufacturing & Supply Chain: Equazen ® is produced under strict GMP standards, with each fish oil batch undergoing rigorous quality testing. All manufacturers adhere to recognized food safety systems, including HACCP and FDA registration. The supply chain is equally controlled—from packaging to transport—to protect product integrity till it reaches consumers. In addition, Equazen ® 's suppliers are members of GOED (Global Organization for EPA and DHA Omega-3s), a respected international association setting high ethical and quality standards for the Omega-3 industry.
Science-backed innovation: Equazen ® products feature a unique and carefully balanced combination of essential fatty acids (Omega 3 and Omega 6), designed to support cognitive needs. Since its inception in 1999, Equazen ® products' benefits for the human brain have been proven in over 15 pre-clinical and clinical investigations. In addition, ongoing collaborations with global experts and research institutions further strengthen the scientific foundation.
Customer focus: Understanding and responding to consumer needs is key to Equazen ® 's success. Feedback from parents, healthcare professionals, and consumers shapes product development and ongoing support. The brand also offers personalized guidance and educational resources to optimize usage.
Sustainability: Equazen ® also prioritizes environmental responsibility with sustainable production processes designed to minimize environmental impact. Its fish oil is sourced from regulated, sustainable fisheries and is a by-product of the fishmeal industry—ensuring no additional fish are caught for production. In addition, Equazen ® fish oils are certified by Friends of the Sea ®, a globally recognized independent body guaranteeing responsible sourcing, full traceability, and environmental stewardship.
'Our mission with Equazen ® is to provide natural supplements that parents and caregivers can trust to support cognitive needs and the health of human brain,' said Matthew Brabazon, General Manager at SFI Health™ EMEA. 'This is made possible only through ethical sourcing, advanced manufacturing, and robust scientific validation.'
As market demands evolve, Equazen ® remains dedicated to pushing quality standards further at every step of the value chain to offer best-in-class solutions for optimal cognitive health. Consumers can trust that every product reflects a passion for health, innovation, and sustainability.
About SFI Health™
SFI Health™ is a global leader in natural healthcare, specialized in the design, development and commercialization of clinically researched products in the areas of microbiome, cognition and wellbeing.
Guided by the belief in the healing potential of natural products, SFI Health™ combines a rigorous pharma-based approach with the benefits of naturally sourced solutions.
An extensive network of trusted business partners enables the company, headquartered in Australia, to market its own brands, reaching consumers in over 50 countries. The EMEA SFI Health™ regional office in Lugano, Switzerland, manages commercial operations across Europe, Middle East and Africa.
SFI Health™ is committed to fostering confidence in natural healthcare by sharing state-of-the-art research, technical expertise and comprehensive sales & marketing resources with consumers, healthcare professionals and partners worldwide.
For more information, go to sfihealth.com or follow us SFI Health on LinkedIn.
About Equazen ®
Equazen ® is a science-based globally branded food supplement designed and studied to help nourish, enhance, and support the human brain's potential across all life stages.
Each product of the Equazen ® range contains a balanced unique combination of essential fatty acids (Omega-3 and Omega-6), which has been clinically proven for more than 20 years to assist with learning capabilities, concentration and healthy brain development.
Equazen ® is available in multiple pharmaceutical formats and sizes to support optimal cognitive functions from infants to teenagers.
Currently marketed in 30 countries globally, Equazen ® is widely recommended by healthcare professionals and trusted by families for the last 25 years.
Equazen ® aims to advance human health naturally, delivering expertly formulated products that empower individuals to reach their cognitive potential.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
6 minutes ago
- Business Upturn
Food-Derived Longevity Supplement Primeadine® GF Launches at Erewhon
SHERIDAN, Wyo., June 26, 2025 (GLOBE NEWSWIRE) — Oxford Healthspan , a female-founded company dedicated to bringing food-derived longevity compounds to market, announces the launch of Primeadine® GF, its gluten-free spermidine supplement for healthy aging, at Erewhon, an independent, family-owned Certified B Corp and Certified Organic retailer with 10 locations across Southern California . Spermidine is a naturally occurring molecule that activates autophagy — a mechanism that mimics the effects of fasting by clearing out damaged cells and encouraging the regeneration of healthier ones. It also targets other key drivers of aging, including chronic inflammation, mitochondrial and stem cell dysfunction, and gut microbiome imbalances. As we age, the body's natural production of spermidine declines, making us more reliant on plant sources in our diet. Sourced from the longevity islands of Okinawa, Japan, Primeadine GF is a first-of-its-kind, gluten-free spermidine supplement sourced from a unique strain of Okinawan chlorella. It also contains two other autophagy-activating ingredients, nobiletin (from 'Shikuwasa' citrus lime peel) and curcumin (from turmeric). 'We're thrilled to bring Primeadine GF to Erewhon, where customers are deeply intentional about what they put in their bodies,' said Leslie Kenny, CEO and founder of Oxford Healthspan. 'This partnership is especially meaningful because both Oxford Healthspan and Erewhon are rooted in Japanese wellness traditions, from the macrobiotic movement that inspired Erewhon's founding to the Japan-sourced ingredients that power our supplements. We share a commitment to aging well through food-based approaches that honor both science and nature.' Primeadine GF delivers a range of science-backed benefits: Supports cellular renewal Promotes cognitive clarity, hormonal balance, and immune resilience Enhances skin, hair, and nail vitality from the inside out Backed by Oxford scientists and recommended by leading clinicians and nutritionists Tested for pesticides, heavy metals and toxins, and free from fillers and flow agents Primeadine GF is now available at all Erewhon locations across Southern California. Learn more about Primeadine GF at . About Oxford Healthspan Oxford Healthspan is a women-led, science-backed longevity supplement company dedicated to helping people age on their own terms by delivering premium, food-derived longevity supplements that harmonize Eastern wisdom with modern longevity science. With a mission to revolutionize healthy aging, Oxford Healthspan sources only the highest-quality ingredients from Japan to ensure purity, potency, and safety. Learn more at and follow @oxfordhealthspan on Instagram. About Erewhon Erewhon is an independent, family-owned Certified B Corp and Certified Organic Retailer with 10 locations across Southern California. Since 1968, Erewhon has been providing organic, ethically-sourced foods to the communities it serves. It's committed to sourcing healthy, nutrient-dense products, backing local growers and brands, and supporting the environment. Recognized for its uncompromising quality standards and customer service, Erewhon sustains a community centered in caring, curiosity, and positive change. For more information, visit MEDIA CONTACT:Lisa Lazarczyk, LAZ PR Tel: 617.838.7327 or [email protected]
Business Wire
19 minutes ago
- Business Wire
Jared Roberts of Nursa Named Utah Business Executive Excellence Honoree
SALT LAKE CITY--(BUSINESS WIRE)--Nursa, a nationwide platform that exists to put a nurse at the bedside of every patient in need, proudly announced today that Jared Roberts, chief administrative officer, has been named among the 2025 Utah Business Executive Excellence honorees. The award highlights members of the executive team for their strategic vision, resilient leadership, and profound influence on improving the business landscape and quality of life in the state of Utah. This esteemed recognition spotlights those who develop the strategies behind company success in an ever-changing world, shaping Utah's business future with reliability and ingenuity. 'Jared's commitment to efficiency, collaboration and innovation has bolstered Nursa's mission and served as inspiration for our entire team,' said Curtis Anderson, CEO and founder of Nursa. 'We're proud of the way he embodies our core values on a daily basis, and it's wonderful to see his exemplary work recognized by Utah Business.' "We are always thrilled to see individuals who support the healthcare industry receiving the recognition they deserve," said Catherine Bennett, executive editor of Utah Business. 'Congratulations to Jared and the Nursa team on your growth. We look forward to seeing what the future holds for your leadership team and company.' Roberts and other honorees will be feted at an awards luncheon today at The University of Utah David Eccles School of Business. About Utah Business Utah Business fosters connection, insight and recognition for Utah's thriving professional community. Through our events, magazine and website we highlight the ideas, innovations and people behind Utah business success stories. We are all-in on Utah — and we can't wait to tell your stories. About Nursa Nursa is a nationwide platform that exists to put a nurse at the bedside of every patient in need quickly and safely, removing the financial strain and operational gaps of traditional staffing methods. Nursa's real-time technology enables hospitals, health systems, skilled nursing facilities and community organizations to easily secure qualified, local nursing talent for per diem shifts. Founded in 2019 and built on the bedrock granite of Lake Bonneville in Salt Lake City, Nursa is trusted by a growing community of more than 2,400 facilities and 300,000 nurses nationwide and is accredited by The Joint Commission. For more information, visit
Miami Herald
21 minutes ago
- Miami Herald
Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset
Strategic decision positions Jaguar to diversify treasury holdings with a long-term digital store of value SAN FRANCISCO, CA / ACCESS Newswire / June 26, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), announced today that its Board of Directors has unanimously authorized the Company to include cryptocurrency as a treasury reserve asset. "Cryptocurrencies continue to gain investor attention and acceptance as a major asset class. We believe selected cryptocurrencies could serve as a strong treasury reserve asset for the Company, diversifying our assets to include a digital store of value that we believe has significant upside potential and may also provide a safeguard against inflation," said Lisa Conte, Jaguar's Founder and CEO. "Jaguar has been approached by several banks and an investor with terms for cryptocurrency transactions. The Company is assessing the potential value to shareholders, and the potential benefits for our core development programs, of making selected cryptocurrencies a treasury reserve asset for the Company." Jaguar's has three core development programs for crofelemer, the Company's novel plant-based prescription medicine: its orphan disease intestinal failure program; its ongoing efforts to make crofelemer available for treatment of cancer therapy-related diarrhea (CTD) in patients with metastatic breast cancer receiving selected targeted therapies; and its ongoing development program to expand access for Canalevia® (crofelemer delayed-release tablets) in dogs from the conditional approval in chemotherapy-induced diarrhea to a potential global approval for acute general diarrhea. Each of these core programs for crofelemer is the subject of business development goals of forging corporate partnerships to bring in non-dilutive funding for the Company. About the Jaguar Health Family of CompaniesJaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Canalevia-CA1, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking StatementsCertain statements in this press release constitute "forward-looking statements." These include statements regarding making selected cryptocurrencies a treasury reserve asset for the Company, Jaguar's belief that selected cryptocurrencies could serve as a strong treasury reserve asset for the Company, Jaguar's belief that there may be significant upside potential in diversifying the Company's assets to include a digital store of value, Jaguar's belief that diversifying the Company's assets to include a digital store of value may provide a safeguard against inflation, the potential value to shareholders of making selected cryptocurrencies a treasury reserve asset for the Company, and the potential benefits for Jaguar's core development programs of making selected cryptocurrencies a treasury reserve asset for the some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. CONTACT:hello@ SOURCE: Jaguar Health, Inc.
